![United States: Patenting Treatments Involving Schedule I Substances - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP](https://cdn.newsserve.net/ONPglobe256.png)
United States: Patenting Treatments Involving Schedule I Substances - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Developing new medical treatments is expensive.
Full Article
Developing new medical treatments is expensive.
Full ArticleThe USPTO seeks feedback from its stakeholders on expanding opportunities to practice before the agency. There are two Federal..